Skip to main content

Find Clinical Trials

Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,775 public trials 831 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study)

NCT06315894

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +16 more
Locations: Germans Trias I Pujol Hospital Badalona, Barcelona, Spain

View Trial Details

Completed

Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic

NCT04421625

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Institut de Cancerologie de l'Ouest Angers, France

Centre Jean Perrin Clermont-Ferrand, France

Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy, France

View Trial Details

Completed

A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment

NCT04359875

Conditions: COVID-19, Cardiovascular Diseases, Chronic Disease, +16 more
Locations: Dibao-Dina Tours, France

View Trial Details

Completed

Buddhist Understanding and Reduction of Myanmar Experiences of HIV Stigma and Exclusion

NCT05126225

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +19 more
Locations: Myanmar Positive Group Yangon, Myanmar, Burma

Chiangmai Rajabhat University Chiang Mai, Thailand

View Trial Details

Completed

A Study to Investigate Safety, Tolerability, and Pharmacokinetics (PK) of VH4524184 and the Potential for Changes in Cytochrome P450 3A (CYP3A) Activity

NCT05631704

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: GSK Investigational Site Baltimore, Maryland, United States

View Trial Details

Completed

Optimizing CAB-LA as PrEP for Women Who Inject Drugs

NCT05799339

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +17 more
Locations: Prevention Point Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Addressing the Continuum of Care Among High-risk Thai Men

NCT05161689

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: M-Health Office Maha Sarakham Maha Sarakham, Thailand

M-Health Office Ubon Ubon Ratchathani, Thailand

View Trial Details

Completed

SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance

NCT03313128

Conditions: Enteric Infections, Environmental Enteric Dysfunction, Infections, +4 more
Locations: Centro de Investigação em Saúde da Polana Caniço (CISPOC) Maputo, Mozambique

View Trial Details

Completed

Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents

NCT04740658

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: University Hospital Toulouse - Gérontopôle Toulouse, France

View Trial Details

Completed

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

NCT06374394

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: GSK Investigational Site Coral Gables, Florida, United States

GSK Investigational Site Savannah, Georgia, United States

GSK Investigational Site Evansville, Indiana, United States

GSK Investigational Site Omaha, Nebraska, United States

View all 24 locations

View Trial Details